WO1988005819A1 - RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT - Google Patents

RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT Download PDF

Info

Publication number
WO1988005819A1
WO1988005819A1 PCT/SU1988/000033 SU8800033W WO8805819A1 WO 1988005819 A1 WO1988005819 A1 WO 1988005819A1 SU 8800033 W SU8800033 W SU 8800033W WO 8805819 A1 WO8805819 A1 WO 8805819A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
dηκ
ppr
interferon
ρρκ
Prior art date
Application number
PCT/SU1988/000033
Other languages
English (en)
French (fr)
Russian (ru)
Inventor
Vladimir Georgievich Debabov
Jury Ivanovich Kozlov
Sergei Vladimirovich Mashko
Alexandr Yakovlevich Strongin
Viktor Emilievich Sterkin
Vitaly Lvovich Jurin
Marina Ivanovna Lebedeva
Maxim Eduardovich Trukhan
Sergei Mikhailovich Podkovyrov
Alla Lvovna Lapidus
Andrei Vladimirovich Mochulsky
Lara Semenovna Izotova
Anna Stanislavovna Ryzhavskaya
Andrei Petrovich Alexenko
Sergei Viktorovich Kostrov
Marina Alexeevna Skvortsova
Valdemaras Vitautovich Gervinskas
Elena Alexeevna Nosovskaya
Ljudmila Vladimirovna Evdonina
Vitaly Arkadievich Livshits
Vladas-Algirdas Vladovich Bumyalis
Sergei Ionovich Borukhov
Tatyana Grigorievna Plotnikova
Alexandr Petrovich Bolotin
Eugenijus-Arvidas Andreevich Yanulaitis
Original Assignee
Vsesojuzny Nauchno-Issledovatelsky Institut Geneti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsesojuzny Nauchno-Issledovatelsky Institut Geneti filed Critical Vsesojuzny Nauchno-Issledovatelsky Institut Geneti
Priority to HU881692A priority Critical patent/HUT50871A/hu
Priority to DE19883890050 priority patent/DE3890050T1/de
Priority to NL8820103A priority patent/NL8820103A/nl
Publication of WO1988005819A1 publication Critical patent/WO1988005819A1/ru
Priority to FI884556A priority patent/FI884556A/fi
Priority to GB8823728A priority patent/GB2208866A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta

Definitions

  • the area of technology is not limited to the field of genetic engineering and biotechnology, and more specifically.
  • the synthesizer used in this case provides an intricate mixture of its various products and functions, which is a result of a complicated operation. This essentially complicates the following properties of individual interactions. ⁇ connection with it more and more
  • the appliance receives the input of individual components from the microprocessor-friendly synthesis.
  • the invention is also a method of combining a p-combination plasmid for D- ⁇ ⁇ 13 ⁇ -13, which is also true for ⁇ ⁇ 24 north,
  • the indicated, the wiring is also the headquarters of the Bacterium ⁇ Igenetica ⁇ 903 ( ⁇ - ⁇
  • the strain is claimed to ensure that the person is safe to eat and / or to eat and / or drink;
  • the method of eliminating the declared industrial requirement for the maintenance of ⁇ > 1-13 is not limited to several stages.
  • the ⁇ - ⁇ zh 1> 1-123 means that the proximity of the ST-sequential gene is closed for the second / second gene
  • the transformer will receive cells ⁇ . ⁇ ⁇ ⁇ 600, which eliminates the stress on the medium with an amperage with a direct voltage and a voltage of 28 ° ⁇ .
  • the battery is suitable for a temperature range of 5 to 40 ° C (optimum 35 ° C) for 6.7-7.5.
  • ⁇ ⁇ aches ⁇ ve is ⁇ chnzh ⁇ a ugle ⁇ da and ⁇ lzuyu ⁇ amin ⁇ zhsl ⁇ y w uglev ⁇ dy (na ⁇ ime ⁇ , sa ⁇ a ⁇ zu) 20 Is ⁇ chni ⁇ m az ⁇ a m ⁇ gu ⁇ sluzhi ⁇ mzhne ⁇ alnye s ⁇ li in nzhyn ⁇ y ⁇ me atm and ⁇ a ⁇ zhe ⁇ ganzhches ⁇ zhe s ⁇ edzhenzhya in vzhde ⁇ e ⁇ na, ⁇ zh ⁇ na, d ⁇ zhzhev ⁇ g ⁇ e ⁇ s ⁇ a ⁇ a w amin ⁇ isl ⁇ Us ⁇ ychzhv ⁇ s ⁇ ⁇ an ⁇ zhbzh ⁇ zh ⁇ am.
  • the strain is stable to concentrate up to 100 mg / l and shruzhzhvanzhi 25 burned on agazirovannyh nutritional
  • Plasma stability P ⁇ zh ⁇ anenzhzh ⁇ le ⁇ on ar ⁇ iz ⁇ vann ⁇ y s ⁇ ede (s ⁇ m I d ⁇ months) ⁇ i se ⁇ zhzh ⁇ sl d ⁇ va ⁇ elny ⁇ ⁇ e ⁇ esev ⁇ v (in ⁇ echenie at least 6 months) in ⁇ tsesse glubzhnn ⁇ g ⁇ ⁇ ul ⁇ ivzh ⁇ vanzhya in zhzhd ⁇ y s ⁇ ede 30 an ⁇ zhbi ⁇ zh ⁇ m not ⁇ zhs ⁇ di ⁇ ⁇ e ⁇ i Well ⁇ e ⁇ es ⁇ y ⁇ zh ⁇ lazm dy.
  • Phase I In fact, even less than the last plasmid is 12 V.
  • 2 mcg of the plasmid ⁇ 24 24 enlarges the local distribution of excrement in 40 flop of the isolation buffer ⁇ .
  • the accessory 3--parts of the participants of the Département I ⁇ . s ⁇ in ⁇ be ⁇ bem ⁇ m m ⁇ l 20, 10 s ⁇ de boiling m ⁇ ⁇ is- ⁇ S ⁇ , ⁇ 8,0, 10 m ⁇ m ⁇ 2, 2 m ⁇ g ⁇ e ⁇ a D ⁇ , ⁇ 30 m ⁇ dez ⁇ si ⁇ zhb ⁇ nu ⁇ le ⁇ zzhd ⁇ zh ⁇ s ⁇ a ⁇ v 5 edzh ⁇ e ⁇ men ⁇ a.
  • Two of the reactive mixtures transfer ethane and dissolve in 100 ⁇ l ⁇ ⁇ ⁇ .
  • the resulting mixture is the translucent bore gasket of the C600 C600.
  • the accessory of the transformer was composed up to 5 » 10 at the same level as the first one at a time ⁇ 24. It obstructs clones that are stable for amplification (100 mcg / ml), but they also emit a separate module for modifying
  • the received message also contains a fragment ( ⁇ ⁇ mulegi ⁇ ) that burns into the receiver ⁇ 24 ⁇ .
  • the obtained product is in the range of 150 ⁇ l, containing 50 mt of trap-n ⁇ terrorism, ⁇ 8.0, 10 mk ⁇ of ethylenejaminetetus, as a result
  • the remote end participants have been remotely operated by an end user of 100 ⁇ l, which is 2 at a time.
  • the nucleotide installed by the method of Sengar, the investigation of the hybrid participation of the communal food in the structure of the device, is the following:
  • Shamazmidu ⁇ ⁇ - ⁇ / 31-13 which supports the synthesis of a human being, has an analogous connection to the bathroom, which is included in the manual
  • 35 ⁇ 903 is around 10 slots on the 1st week of August - 16 - ⁇ ⁇ whatsoever ⁇ Operations ⁇ - ⁇ - ⁇ . Particles are removed from a medium containing amperage (100 ⁇ g / ml) after a fresh bulb is removed at a temperature of 28 ° C. From all the oblique, they isolate plasmid DB
  • the facility is equipped with a fully equipped facility.
  • the medium is available at 100 ⁇ g / ml and 10 g / l glucose.
  • the seed crop is introduced in the range of 5-10 ma.
  • the 25th is the level of supply of ammonia water. Part Pe ⁇ vuyu ⁇ e ⁇ men ⁇ atszhzh ⁇ v ⁇ dya ⁇ ⁇ zh ⁇ em ⁇ e ⁇ a ⁇ u ⁇ e 28 ° C d ⁇ ⁇ zhches ⁇ ⁇ l ⁇ n ⁇ s ⁇ zh, ⁇ avn ⁇ y 3.5 ⁇ i 550 nm and za ⁇ em ⁇ susches ⁇ vlyayu ⁇ ⁇ e ⁇ d ⁇ zhndu ⁇ zhyu, ⁇ vyshaya ⁇ em ⁇ e ⁇ a ⁇ u ⁇ u d ⁇ 42-45 ° C in a 5 ⁇ echenzh mzhn, ⁇ sle cheg ⁇ ⁇ d ⁇ lzhayu ⁇ ⁇ e ⁇ len ⁇ atszhyu still chasa 2 ⁇
  • Zayavlyaemyzh sh ⁇ amm ba ⁇ e ⁇ y ⁇ zs ⁇ eg ⁇ s ⁇ and s ⁇ ⁇ IIgene ⁇ i ⁇ a ⁇ ⁇ 903 ( ⁇ - ⁇ Y ⁇ - ⁇ z> - ⁇ dutsen ⁇ /> 1-iya ⁇ e ⁇ e ⁇ on chel ⁇ ve ⁇ a na ⁇ di ⁇ ⁇ zhmenenie in mi ⁇ bi ⁇ l ⁇ giches ⁇ y and meditsins ⁇ y ⁇ myshleyan ⁇ s ⁇ i ⁇ lucheniya for 1 h 15 in ⁇ e ⁇ e ⁇ na l ⁇ ve ⁇ a, ⁇ y m ⁇ zhe ⁇ ⁇ imenya ⁇ sya in meditsins ⁇ y ⁇ a ⁇ i ⁇ e .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PCT/SU1988/000033 1987-02-09 1988-02-08 RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT WO1988005819A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HU881692A HUT50871A (en) 1987-02-09 1988-02-08 Process for producing recombinant plasmid dna encoding human fibroblast-beta 1-interferon and escherichia coli comprising same
DE19883890050 DE3890050T1 (de) 1987-02-09 1988-02-08 Rekombination-plasmid-dns ppr-ifn(beta)1-13 die die synthese des menschlichen fibroblast-(beta)1-interferons kodiert, verfahren zum konstruieren derselben und stamm der bakterien
NL8820103A NL8820103A (nl) 1987-02-09 1988-02-08 Recombinant plasmide dna - phr-ifnbeta 1-13 coderende synthese van fibroblastisch humaan beta1-interferon, werkwijze ter bereiding ervan en een stam van de bacterie escherichia coli vniigenetika vl 903 (phr-ifnbeta1-13), die humaan beta1-interferon vormt, die dit bevat.
FI884556A FI884556A (fi) 1987-02-09 1988-10-04 Rekombinantplasmid-dna ppr-ifn 1-13, som kodas foer syntes av maenniskans fibroblast- 1-interferon, foerfarande foer framstaellning daerav och e.coli innehaollande detta.
GB8823728A GB2208866A (en) 1987-02-09 1988-10-10 Recombinant plasmid dna ppr-ifn¼-13, coding for synthesis of human fidroblast ¼-1 interferon, and strain of bacteria escherichia coli vniigenetika vl903

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU874191345A SU1703692A1 (ru) 1987-02-09 1987-02-09 Рекомбинантна плазмидна ДНК @ -1 @ 1-13, кодирующа синтез фибробластного интерферона ( @ I) человека, способ ее конструировани , штамм бактерий ЕSснеRIснIа coLI - продуцент @ I-интерферона человека
SU4191345/28 1987-02-09

Publications (1)

Publication Number Publication Date
WO1988005819A1 true WO1988005819A1 (en) 1988-08-11

Family

ID=21284355

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SU1988/000033 WO1988005819A1 (en) 1987-02-09 1988-02-08 RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT

Country Status (9)

Country Link
JP (1) JPH01502478A (fi)
CH (1) CH676996A5 (fi)
FI (1) FI884556A (fi)
GB (1) GB2208866A (fi)
HU (1) HUT50871A (fi)
NL (1) NL8820103A (fi)
SE (1) SE8803567D0 (fi)
SU (1) SU1703692A1 (fi)
WO (1) WO1988005819A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593792B2 (en) * 1992-10-14 2004-01-07 Ajinomoto Co., Inc. Novel L-threonine-producing microbacteria and a method for the production of L-threonine
ATE501168T1 (de) * 2004-12-20 2011-03-15 Cadila Healthcare Ltd Verfahren zur herstellung von hohen niveaus von interferon-beta

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Biotekhnologia", pod, red. A.A. BAEVE, 1984, Nauka, (Moscow), pages 204-205. *
ZHURNAL VSESOJUZNOGO KHIMICHESKOGO OBSCHESTVA IM. D. I. MENDELCEVA, tom XXIX Nr. 2, 1984, (Khimia, Moscow), E.D. SVERDLOV, "Interferony i Geneticheskaya Inzheneria", pages 86-89, (206-209). *

Also Published As

Publication number Publication date
FI884556A0 (fi) 1988-10-04
SE8803567L (sv) 1988-10-07
FI884556A (fi) 1988-10-04
NL8820103A (nl) 1989-01-02
GB2208866A (en) 1989-04-19
JPH01502478A (ja) 1989-08-31
HUT50871A (en) 1990-03-28
SE8803567D0 (sv) 1988-10-07
CH676996A5 (fi) 1991-03-28
SU1703692A1 (ru) 1992-01-07
GB8823728D0 (en) 1988-12-07

Similar Documents

Publication Publication Date Title
Kato et al. Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light
EP0131623B1 (en) Chimeric genes suitable for expression in plant cells
WO2020059962A1 (ko) Bip 단편을 포함하는 재조합 벡터 및 상기 벡터를 이용한 재조합 단백질의 제조 방법
CN110760511A (zh) 一种用于治疗杜氏肌营养不良症的gRNA、表达载体、CRISPR-Cas9系统
WO1988005819A1 (en) RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT
JPS62163694A (ja) 宿生バチルス属微生物の異種構造形質転換方法
US5330753A (en) Cholera vaccines
WO1989011541A1 (en) Extraction of human interleukin-4 from bacteria
CN107893081A (zh) 一种人源角质细胞生长因子‑2的基因序列、表达载体及生产方法
JPS633793A (ja) Ix因子の発現を確実にする真核細胞内組込みベクタ−、得られた細胞系、およびこれらの製造方法
CN101948865B (zh) 一种双启动子可诱导可分泌型穿梭质粒及其构建方法
US5021340A (en) Cloning vector, molecules of recombinant DNA, bacillus subtilis strains transformed with the said molecules and methods for the expression of heterologous genes and the production and secretion of proteins coded by the said genes
JPS59501852A (ja) 鳥類の成長ホルモン
Sorge Bacteriophage lambda cloning vectors
WO1988005818A1 (en) RECOMBINANT PLASMID DNA pPR-IL2-19, CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IL2-19) AS PRODUCER OF HUMAN INTERLEUKIN-2, CONTAINING IT
EP0358692B1 (en) Cholera vaccines
CN113943689B (zh) 一种免疫激活性重组乳酸乳球菌的构建及作为肿瘤疫苗和免疫佐剂等方面的应用
CN114984189B (zh) 一种白细胞介素16蛋白的新用途
CN109486851B (zh) 一种提高胚乳生物反应器中重组蛋白表达水平的方法
WO1987006613A1 (en) RECOMBINANT PLASMID DNA pVN22, CODING FOR BIOSYNTHESIS OF HUMAN LEUCOCYTE INTERFERON alpha-I1 AND STRAIN PSEUDOMONAS sp. 31 (pVN22) - PRODUCER OF HUMAN LEUCOCYTE INTERFERON alpha-I1 CONTAINING IT
Bealde et al. Gene structure and gene action
AU583018B2 (en) Gibbon interleukin
WO1984003300A1 (en) Leukocytic human interferon n and method to obtain it in bacterial cells
CN101684468B (zh) 一种人工合成的人胰岛素基因及其在培育转基因番茄中的应用
KR101288502B1 (ko) 식물 형질전환용 바이너리 벡터

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CH DE FI GB HU JP NL SE US

WWE Wipo information: entry into national phase

Ref document number: 884556

Country of ref document: FI

RET De translation (de og part 6b)

Ref document number: 3890050

Country of ref document: DE

Date of ref document: 19890413

WWE Wipo information: entry into national phase

Ref document number: 3890050

Country of ref document: DE